Kort præsentation

Janine Erler is a Group Leader at BRIC, University of Copenhagen. She graduated as BSc with Honours in Molecular Genetics from the University of Sussex (UK) in 2000 and was awarded a PhD in Molecular Pharmacology from the University of Manchester (UK) in 2003 for her research on hypoxia-regulated resistance of cancer cells to chemotherapy. Between 2004 and 2008, Dr Erler was a postdoctoral training fellow in the laboratory of Prof Amato Giaccia at Stanford University (USA), where she started working on hypoxia-regulated metastasis and identified lysyl oxidase (LOX) as a key mediator. She then started her own independent research group in 2008 at the Institute of Cancer Research in London (UK). Dr Erler moved her lab to BRIC in 2012. She has received numerous awards for her research including the BACR Translational Research Award (2009) and the BACR/AstraZeneca Young Scientist Frank Rose Award (2012), and was the first woman to receive the prestigious Novo Nordisk Hallas Møller Stipendum (2012).

Primære forskningsområder

Cancer Biology

Tumour Microenvironment

Metastasis

Translational Research

CV

EDUCATION

2000-2003         University of Manchester, UK, School of Biological Sciences

                        PhD Molecular Pharmacology: “The impact of tumour hypoxia on drug-induced apoptosis”

1996-2000        University of Sussex, UK, School of Biological Sciences

                       BSc (Hons) 1^st Class, Molecular Genetics in Biotechnology (with Industrial Placement)

1989-1996       The European School, Culham, Oxfordshire, UK

                       European Baccalaureate: 13 subjects, 7.9 (out of 10) overal

RECENT WORK EXPERIENCE

2012-present   Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Denmark

                      Group Leader, tumour microenvironment

2008-2012     The Institute of Cancer Research, London, UK, Division of Cancer Biology

                     Team Leader, hypoxia and metastasis

2004-2008     Stanford University, USA, Department of Radiation Oncology

                     Postdoctoral Fellow, hypoxia and metastasis

1998-1999     AstraZeneca Pharmaceuticals, Cheshire, UK,

                     Cardiovascular Metabolism and Musculoskeletal Research

                     Industrial Placement student, researching obesity

1995              Bayer AG, Leverkusen, Germany

                     Summer student, biotechnology research